The U.S. Government Accountability Office (GAO) has issued a report titled “Electronic Drug Labeling: No Consensus on the Advantages and Disadvantages of Its Exclusive Use.” Based on a review of U.S. Food and Drug Administration guidance documents and regulations and interviews with federal officials and stakeholders, the report concluded that barriers remain to eliminating paper labeling entirely. While supporters of electronic labeling touted its advantages in terms of information currency and potential interactivity to enhance patients’ knowledge about the drugs they use, others contended that too many may be uncomfortable using the medium or find it inconvenient or even unavailable. Some questioned whether multiple electronic sources of information would be reliable and unbiased.